These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35649315)

  • 1. Structure-Based design of [(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine derivatives as nonnucleoside HIV-1 reverse transcriptase Inhibitors: From HEPTs to Sulfinyl-substituted HEPTs.
    Hao Q; Wang S; Huang W; Zhang Y; Pannecouque C; De Clercq E; Chen F
    Bioorg Chem; 2022 Sep; 126():105880. PubMed ID: 35649315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-directed linker optimization of novel HEPTs as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Hao QQ; Chen XM; Pannecouque C; De Clercq E; Wang S; Chen FE
    Bioorg Chem; 2023 Apr; 133():106413. PubMed ID: 36791619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
    Chen W; Zhan P; Wu J; Li Z; Liu X
    Curr Pharm Des; 2012; 18(27):4165-86. PubMed ID: 22621244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
    Kireev DB; Chrétien JR; Grierson DS; Monneret C
    J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.
    Mao Y; Li Y; Hao M; Zhang S; Ai C
    J Mol Model; 2012 May; 18(5):2185-98. PubMed ID: 21947448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
    Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
    Douali L; Villemin D; Zyad A; Cherqaoui D
    Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
    Douali L; Villemin D; Cherqaoui D
    J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
    Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel HEPT analogs featuring significantly improved anti-resistance potency against HIV-1 through chemical space exploration of the tolerant region I.
    Zhou RL; Pannecouque C; De Clercq E; Wang S; Chen FE
    Bioorg Chem; 2023 Nov; 140():106783. PubMed ID: 37595396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
    Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues.
    Ji L; Chen FE; Feng XQ; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1248-53. PubMed ID: 16946529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.
    Zhao T; Meng Q; Kang D; Ji J; De Clercq E; Pannecouque C; Liu X; Zhan P
    Eur J Med Chem; 2019 Nov; 182():111619. PubMed ID: 31434039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided design of novel HEPT analogs with enhanced potency and safety: From Isopropyl-HEPTs to Cyclopropyl-HEPTs.
    Zhou RL; Ju Z; Pannecouque C; Clercq E; Wang S; Chen FE
    Eur J Med Chem; 2023 Jan; 246():114939. PubMed ID: 36442370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors.
    Chen X; Ding L; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
    Eur J Med Chem; 2020 Sep; 202():112549. PubMed ID: 32712537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures.
    Gaudio AC; Montanari CA
    J Comput Aided Mol Des; 2002 Apr; 16(4):287-95. PubMed ID: 12400858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Jan; 35(2):337-45. PubMed ID: 1732552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
    Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.